Total Payments
$8,292
2024 Payments
$370.68
Companies
23
Transactions
124
Medicare Patients
6,161
Medicare Billing
$3.1M
Payment Breakdown by Category
Consulting$5,250 (63.3%)
Food & Beverage$2,566 (31.0%)
Travel$445.57 (5.4%)
Education$29.89 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $5,250 | 1 | 63.3% |
| Food and Beverage | $2,566 | 119 | 31.0% |
| Travel and Lodging | $445.57 | 2 | 5.4% |
| Education | $29.89 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $6,079 | 16 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $824.05 | 36 | $0 (2024) |
| Genentech USA, Inc. | $219.45 | 11 | $0 (2024) |
| Apellis Pharmaceuticals, Inc. | $188.85 | 10 | $0 (2024) |
| Shire North American Group Inc | $117.81 | 6 | $0 (2019) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $115.16 | 6 | $0 (2021) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $113.92 | 6 | $0 (2021) |
| Alimera Sciences, Inc. | $112.74 | 6 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $112.08 | 6 | $0 (2021) |
| ABBVIE INC. | $57.55 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $370.68 | 19 | Regeneron Healthcare Solutions, Inc. ($229.39) |
| 2023 | $507.52 | 23 | Regeneron Healthcare Solutions, Inc. ($189.55) |
| 2022 | $266.49 | 12 | Regeneron Healthcare Solutions, Inc. ($155.36) |
| 2021 | $351.73 | 16 | Regeneron Healthcare Solutions, Inc. ($141.94) |
| 2020 | $186.46 | 9 | Regeneron Healthcare Solutions, Inc. ($71.96) |
| 2019 | $6,330 | 31 | Allergan Inc. ($6,025) |
| 2018 | $159.93 | 8 | Allergan Inc. ($53.25) |
| 2017 | $119.36 | 6 | Shire North American Group Inc ($80.69) |
All Payment Transactions
124 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/20/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $5.29 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/20/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $3.14 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/26/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: Ophthalmology | ||||||
| 10/29/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $26.53 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/26/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/11/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $33.50 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/03/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: Ophthalmology | ||||||
| 08/14/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $33.67 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/26/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: Immunology and Ophthalmology | ||||||
| 05/30/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $8.58 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/24/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/24/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/21/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Ophthalmology | ||||||
| 03/27/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/26/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $3.62 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/21/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 01/25/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $39.42 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/19/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/20/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $28.63 | General |
| Category: DRY EYE | ||||||
| 12/19/2023 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | Cash or cash equivalent | $16.35 | General |
| Category: Ophthalmology | ||||||
| 11/30/2023 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Education | Cash or cash equivalent | $17.19 | General |
| Category: Ophthalmology | ||||||
| 11/11/2023 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | Cash or cash equivalent | $19.31 | General |
| Category: Ophthalmology | ||||||
| 11/08/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $7.33 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/01/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $30.63 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,629 | 8,001 | $5.7M | $910,895 |
| 2022 | 11 | 1,700 | 4,370 | $5.4M | $838,013 |
| 2021 | 12 | 1,487 | 3,925 | $4.7M | $761,135 |
| 2020 | 10 | 1,345 | 3,215 | $3.9M | $634,112 |
Total Patients
6,161
Total Services
19,511
Medicare Billing
$3.1M
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 96 | 836 | $3.5M | $571,108 | 16.5% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 573 | 1,319 | $501,617 | $119,517 | 23.8% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 17 | 3,660 | $208,949 | $106,125 | 50.8% |
| 67028 | Injection of drug into eye | Office | 2023 | 147 | 602 | $992,532 | $54,575 | 5.5% |
| 92134 | Imaging of retina | Office | 2023 | 569 | 1,258 | $347,208 | $37,356 | 10.8% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 41 | 136 | $56,940 | $10,636 | 18.7% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 56 | 56 | $23,881 | $4,777 | 20.0% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 40 | 40 | $31,680 | $4,259 | 13.4% |
| 92250 | Photography of the retina | Office | 2023 | 67 | 71 | $25,986 | $1,850 | 7.1% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 12 | 12 | $6,156 | $455.51 | 7.4% |
| 92133 | Imaging of optic nerve | Office | 2023 | 11 | 11 | $3,036 | $236.64 | 7.8% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 98 | 840 | $3.5M | $600,793 | 17.3% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 626 | 1,320 | $372,240 | $119,353 | 32.1% |
| 67028 | Injection of drug into eye | Office | 2022 | 152 | 624 | $1.0M | $56,995 | 5.6% |
| 92134 | Imaging of retina | Office | 2022 | 604 | 1,216 | $335,616 | $36,375 | 10.8% |
| J7999 | Compounded drug, not otherwise classified | Office | 2022 | 59 | 200 | $82,290 | $13,946 | 16.9% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 41 | 41 | $13,038 | $4,256 | 32.6% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2022 | 29 | 29 | $22,968 | $2,850 | 12.4% |
| 92250 | Photography of the retina | Office | 2022 | 55 | 63 | $22,863 | $1,666 | 7.3% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 12 | 13 | $2,548 | $881.42 | 34.6% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 13 | 13 | $6,669 | $566.75 | 8.5% |
| 92133 | Imaging of optic nerve | Office | 2022 | 11 | 11 | $3,036 | $332.83 | 11.0% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2021 | 76 | 736 | $3.0M | $542,214 | 17.8% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 558 | 1,183 | $333,606 | $108,434 | 32.5% |
| 67028 | Injection of drug into eye | Office | 2021 | 129 | 575 | $904,410 | $53,105 | 5.9% |
About Dr. Bailey Lee, MD
Dr. Bailey Lee, MD is a Ophthalmology healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1619962461.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bailey Lee, MD has received a total of $8,292 in payments from pharmaceutical and medical device companies, with $370.68 received in 2024. These payments were reported across 124 transactions from 23 companies. The most common payment nature is "Consulting Fee" ($5,250).
As a Medicare-enrolled provider, Lee has provided services to 6,161 Medicare beneficiaries, totaling 19,511 services with total Medicare billing of $3.1M. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Houston, TX
- Active Since 09/19/2005
- Last Updated 05/28/2025
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1619962461
Products in Payments
- OZURDEX (Drug) $6,136
- EYLEA (Biological) $524.57
- EYLEA HD (Biological) $299.48
- XIIDRA (Drug) $175.21
- Syfovre (Drug) $166.99
- Vabysmo (Drug) $121.50
- VYZULTA (Drug) $78.45
- Iluvien (Drug) $66.44
- Lucentis (Biological) $56.43
- TYRVAYA (Drug) $52.30
- AcrySof IQ PanOptix (Device) $42.57
- LOTEMAX SM (Drug) $39.85
- XELPROS (Drug) $38.18
- Cequa (Drug) $36.86
- BEOVU (Drug) $35.73
- VABYSMO (Drug) $27.07
- AVANCE NERVE GRAFT (Device) $24.06
- DARAPRIM (Drug) $23.75
- Daraprim Tablet 25mg (Drug) $23.75
- rocklatan (Drug) $22.25
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Houston
Stephen Slade, M.d, M.D
Ophthalmology — Payments: $1.5M
Ophthalmology $1.5M
Dr. Christina Weng, M.d., M.b.a, M.D., M.B.A
Ophthalmology — Payments: $635,330
Ophthalmology $635,330
Zaina Al-Mohtaseb, Md, MD
Ophthalmology — Payments: $559,665
Ophthalmology $559,665
Dr. John Micheletti, M.d, M.D
Ophthalmology — Payments: $555,738
Ophthalmology $555,738
David Brown, M.d, M.D
Ophthalmology — Payments: $488,095
Ophthalmology $488,095
Dr. Douglas Koch, M.d, M.D
Ophthalmology — Payments: $457,260
Ophthalmology $457,260